{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "31722-597",
      "generic_name": "Ritonavir",
      "labeler_name": "Camber Pharmaceuticals, Inc.",
      "brand_name": "Ritonavir",
      "active_ingredients": [
        {
          "name": "RITONAVIR",
          "strength": "100 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "31722-597-12",
          "description": "120 TABLET in 1 BOTTLE (31722-597-12)",
          "marketing_start_date": "20180917",
          "sample": false
        },
        {
          "package_ndc": "31722-597-30",
          "description": "30 TABLET in 1 BOTTLE (31722-597-30)",
          "marketing_start_date": "20180917",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Camber Pharmaceuticals, Inc."
        ],
        "rxcui": [
          "900575"
        ],
        "spl_set_id": [
          "db633374-6d8e-4622-9fe1-f9d68baa59bb"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0331722597302",
          "0331722597128"
        ],
        "nui": [
          "N0000000246",
          "N0000191001",
          "N0000175889",
          "N0000190114",
          "N0000182137",
          "N0000185607",
          "N0000190118",
          "N0000185503",
          "N0000190113",
          "N0000182141",
          "N0000191266",
          "N0000185507",
          "N0000187064",
          "N0000190117"
        ],
        "pharm_class_moa": [
          "HIV Protease Inhibitors [MoA]",
          "Cytochrome P450 3A Inhibitors [MoA]",
          "Cytochrome P450 2D6 Inhibitors [MoA]",
          "Cytochrome P450 2C19 Inducers [MoA]",
          "Cytochrome P450 3A Inducers [MoA]",
          "P-Glycoprotein Inhibitors [MoA]",
          "Breast Cancer Resistance Protein Inhibitors [MoA]",
          "Cytochrome P450 3A4 Inhibitors [MoA]",
          "Cytochrome P450 1A2 Inducers [MoA]",
          "Cytochrome P450 2C9 Inducers [MoA]",
          "Cytochrome P450 2B6 Inducers [MoA]",
          "UDP Glucuronosyltransferases Inducers [MoA]"
        ],
        "pharm_class_epc": [
          "Cytochrome P450 3A Inhibitor [EPC]",
          "Protease Inhibitor [EPC]"
        ],
        "unii": [
          "O3J8G9O825"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET",
      "spl_id": "f5490379-7440-5901-e053-2a95a90ac1f4",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20180917",
      "product_id": "31722-597_f5490379-7440-5901-e053-2a95a90ac1f4",
      "application_number": "ANDA204587",
      "brand_name_base": "Ritonavir",
      "pharm_class": [
        "Breast Cancer Resistance Protein Inhibitors [MoA]",
        "Cytochrome P450 1A2 Inducers [MoA]",
        "Cytochrome P450 2B6 Inducers [MoA]",
        "Cytochrome P450 2C19 Inducers [MoA]",
        "Cytochrome P450 2C9 Inducers [MoA]",
        "Cytochrome P450 2D6 Inhibitors [MoA]",
        "Cytochrome P450 3A Inducers [MoA]",
        "Cytochrome P450 3A Inhibitor [EPC]",
        "Cytochrome P450 3A Inhibitors [MoA]",
        "Cytochrome P450 3A4 Inhibitors [MoA]",
        "HIV Protease Inhibitors [MoA]",
        "P-Glycoprotein Inhibitors [MoA]",
        "Protease Inhibitor [EPC]",
        "UDP Glucuronosyltransferases Inducers [MoA]"
      ]
    }
  ]
}